Update
$Syros Pharmaceuticals(SYRS.US$ Syros Receives Fast Track Designation From The FDA For Tamibarotene For The Treatment Of Newly Diagnosed Unfit AML With RARA Gene Overexpression
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
